ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells

Properties of cancer stem cells involved in drug resistance and relapse have significant effects on clinical outcome. Although tyrosine kinase inhibitors (TKIs) have dramatically improved survival of patients with chronic myeloid leukemia (CML), TKIs have not fully cured CML due to TKI-resistant CML...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyauchi, Masashi, Koya, Junji, Arai, Shunya, Yamazaki, Sho, Honda, Akira, Kataoka, Keisuke, Yoshimi, Akihide, Taoka, Kazuki, Kumano, Keiki, Kurokawa, Mineo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919294/
https://www.ncbi.nlm.nih.gov/pubmed/29429960
http://dx.doi.org/10.1016/j.stemcr.2018.01.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919294/
https://www.ncbi.nlm.nih.gov/pubmed/29429960
http://dx.doi.org/10.1016/j.stemcr.2018.01.015

Ejemplares similares